Complications of endovascular treatment for acute stroke in the SWIFT trial with Solitaire and Merci devices

American Journal of Neuroradiology

Volumn 35, Issue 3, 2014, Pages 524-528

  Akins, Paul T ^a   Amar, A P ^b   Pakbaz, R S ^c   Fields, J D ^d  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; AIR EMBOLISM; ANGIOGRAPHY; ARTERY DISSECTION; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBOLECTOMY SYSTEM; EMBOLISM; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HUMAN; INGUINAL REGION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANDOMIZED CONTROLLED TRIAL; SOLITAIRE FR RETRIEVAL DEVICE; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; THROMBECTOMY; THROMBECTOMY DEVICE; VASOSPASM; YOUNG ADULT; CLINICAL TRIAL; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY; STROKE;

ADULT; AGED; ENDOVASCULAR PROCEDURES; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STROKE; THROMBECTOMY; YOUNG ADULT;

EID: 84896469188     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3707     Document Type: Article

References (22)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-87
2. Rha J, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73 (Pubitemid 46568460)
3. Tenser MS, Amar AP, Mack WJ. Mechanical thrombectomy for acute ischemic stroke using the Merci retriever and Penumbra aspiration systems. World Neurosurg 2011;76(6 Suppl):S16-23
4. Del Zoppo GJ, Higashida RT, Furlan AJ, et al, and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11 (Pubitemid 28046933)
5. Furlan A, Higashida R, Wechsler L, et al, for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial JAMA 1999;282:2003-11
6. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11
7. Smith WS, Sung G, Starkman S, et al, for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke 2005;36:1432-40
8. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35
9. Bose A, Henkes H, Alfke K, et al, for the Penumbra Phase 1 Stroke Trial Investigators. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13
10. Smith WS, Sung G, Saver J, et al Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12 (Pubitemid 351440692)
11. Miteff F, Faulder KC, Goh AC, et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral occlusion. AJNR Am J Neuroradiol 2011;32:1078-81
12. Machi P, Costalat V, Lobotesis K, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62-66
13. Saver JL, Jahan R, Levy EI, et al, for the SWIFT trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. Lancet 2012;380:1241-49
14. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1984;33:523-30
15. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 (http://ctep.cancer.gov), Publish Date: August 9, 2006
16. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25
17. Shi Z-S, Liebeskind DS, Loh Y, et al and UCLA Endovascular Stroke Therapy Investigators. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775-81
18. Khatri P, Broderick JP, Khoury JC, et al, IMS I and II Investigators. Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283-87
19. Teal PA, Pessin MS. Hemorrhagic transformation: the spectrum of ischemia-related brain hemorrhage. Neurosurg Clin North Am 1992;3:601-10
20. Mehra M, Hendricks GH, O'Callaghan JM, et al. Preclinical in-vivo safety evaluation of thrombectomy devices in the canine cerebrovasculature (abstract). Stroke 2012;43:A139
21. Broderick JP, Palesch YY, Demchuk AM, et al, for the IMS III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903
22. Pausch R. The Last Lecture. New York: Hyperion Books; 2008